Date:5/19/2010

pan> over the same year ago period. This increase was driven by higher sales volumes accompanied by increased prices for specialty cotton, which doubled during the first quarter of 2010 to $1631 per ton compared to the year ago period. The two key raw materials required for the production of cellulose ether products are purified cotton and etherifying epoxy propane. The Company is based in Feicheng City, which is located in the Shandong Province, a region known for its cotton production, and also home to a number of large etherifying epoxy propane producers. Corresponding gross profits for the quarter were 32.3% compared to 39.5% for the first quarter of 2009. The fluctuation of the cotton price is primarily due to the severe drought in China which has led to decreased supply. While cotton prices during the first quarter reached historical highs, management decided to maintain selling prices, while the majority of our competitors increased selling prices to match costs. Several small competitors exited the market as result of the Company's strategy. As cotton prices have remained elevated during the second quarter, China Ruitai increased selling prices to more adequately reflect production costs, with the goal of achieving gross margins close to historical levels.

Selling expenses which consist of sales commissions, freight charges, and travel were $0.4 million for the three month period ended March 31, 2010 an increase of approximately 24.3% compared to the first quarter of 2009. This increase was due to increased transportation costs and increased sales commissions associated with increased sales.

General and administrative expenses totaled $0.3 million for the three month period ended
'/>"/>

SOURCE China Ruitai International Holdings Co., Ltd. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. China Sky One Medical Announces First Quarter 2010 Results
2. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
3. China Biologic Products Announces First Quarter 2010 Results
4. China Sky One Medicals CEO Receives Award For "Leadership Excellence In Innovation"
5. China Sky One Medical to Attend Investment Conferences in May
6. China Biologic Products to Build Two New Plasma Stations in Shandong Province
7. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
8. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
9. China Pharma Holdings, Inc. Announces May Investor Conference Participation
10. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
11. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010